HSS: New Cell Signaling Pathway Important In RA

Orthopedics This Week—October 29, 2014

A team of researchers from Hospital for Special Surgery (HSS) has identified a new cell signaling pathway that contributes to the development and progression of inflammatory bone erosion, which occurs in patients with rheumatoid arthritis (RA).

 "We are very excited about our results, because this newly identified RBP-J-controlled signaling pathway will provide potential novel therapeutic targets for the prevention and treatment of RA, thus opening a new avenue for both basic research and clinical care," said Dr. Zhao in the news release.

The new technology and analysis were supported by the David Z. Rosensweig Genomics Research Center at HSS, which is supported by The Tow Foundation and led by Lionel B. Ivashkiv, M.D., associate chief scientific officer at HSS. Dr. Zhao is also a member of this center. The study was supported by research grants from the National Institutes of Health (NIH).

Read Full Story at Orthopedics This Week.


Find a Physician

Conditions & Treatments

graphic: adult outline graphic: child outline
Select A Body Part
Conditions: Adult head Conditions: Adult spine Conditions: Adult shoulder Conditions: Adult elbow Conditions: Adult hand Conditions: Adult hip Conditions: Adult knee Conditions: Adult ankle Conditions: Adult head Conditions: Adult full body Conditions: Child spine Conditions: Child elbow Conditions: Child hip Conditions: Child hand Conditions: Child knee Conditions: Child ankle Conditions: Child full body

Complete Listing »

Media Contacts

Tracy Hickenbottom
Monique Irons
Sherry Randolph


Social Media Contacts

Andrew Worob
Otis Gamboa